Inactive Instrument

Cronos Group Inc Stock Toronto S.E.

Equities

CA22717L1013

Pharmaceuticals

Sales 2024 * 137M 99.72M Sales 2025 * 164M 119M Capitalization 1.27B 925M
Net income 2024 * -17M -12.36M Net income 2025 * -10M -7.27M EV / Sales 2024 * 0.62 x
Net cash position 2024 * 1.19B 863M Net cash position 2025 * 1.19B 866M EV / Sales 2025 * 0.49 x
P/E ratio 2024 *
-54.2 x
P/E ratio 2025 *
-48.5 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 52.38%
More Fundamentals * Assessed data
Dynamic Chart
Cannabis Stocks: Wedbush Notes Florida Supreme Court Approved Proposed Amendment For Adult Use Cannabis to be Placed on the 2024 General Election Ballot MT
Cronos Group Brief: Launching 'Lord Jones' Chocolate Fusions MT
Cronos Group Inc. Launches Lord Jones Chocolate Fusions CI
Aurora, Canopy Among Cannabis Stocks Rising After Germany Passes Partial Legalization Law MT
Aurora Cannabis, Canopy Growth Among Cannabis Stocks Rising After Germany Passes Partial Legalization Law MT
Cronos Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Toronto Stocks Advance; Canadian Imperial Bank of Commerce Up on 1Q Profit, Revenue Rise DJ
Cronos Group Reports Consolidated Net Revenue Rose 9% in Q4 2023 MT
Transcript : Cronos Group Inc., Q4 2023 Earnings Call, Feb 29, 2024
Cronos Group Brief: Says Ended 2023 with approximately US$862 million in cash and short-term investments MT
Cronos Group Brief: Net revenue in Canada increased 20% in Q4 2023 Vs Q4 2022; On a constant currency basis net revenue in Canada increased 21% in Q4 2023 Vs Q4 2022 MT
Cronos Group Brief: On a constant currency basis consolidated net revenue increased 11% in Q4 2023 compared to Q4 2022 MT
Cronos Group Brief: Consolidated net revenue increased 9% in Q4 2023 compared to Q4 2022 MT
Cronos Group Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
North American Morning Briefing : Fed's Preferred -2- DJ
More news
Managers TitleAgeSince
Chief Executive Officer 37 15-11-05
Director of Finance/CFO 41 22-11-13
Chief Tech/Sci/R&D Officer 41 -
Members of the board TitleAgeSince
Director/Board Member 48 21-06-24
Director/Board Member 57 18-01-31
Director/Board Member 52 16-07-11
More insiders
Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s international brand portfolio includes Spinach, PEACE NATURALS, and Lord Jones. The Lord Jones are hemp-derived cannabidiol (CBD) brand. Its Lord Jones Hash Fusions is a line-up of premium ice water hash infused pre-rolls. Its PEACE NATURALS offers Peppermint CBD, a blend of CBD extract, quality medium-chain triglycerides (MCT) oil, and a hint of natural peppermint flavor.
More about the company